The concept of synthetic lethality in the context of anticancer therapy (Q28268061)

Systematic genetic analysis with ordered arrays of yeast deletion mutants

Europe PubMed Central

title

The concept of synthetic lethality in the context of anticancer therapy (English)

0 references

1

William G Kaelin

0 references

language of work or name

English

0 references

publication date

September 2005

0 references

published in

Nature Reviews Cancer

0 references

volume

5

0 references

page(s)

689-98

0 references

issue

9

0 references

cites work

1 reference

Global mapping of the yeast genetic interaction network

21 April 2017

1 reference

Proliferation, cell cycle and apoptosis in cancer

21 April 2017

1 reference

Hsp90 as a capacitor for morphological evolution

21 April 2017

1 reference

Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase

21 April 2017

1 reference

Cdk2 knockout mice are viable

21 April 2017

1 reference

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 April 2017

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 April 2017

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 April 2017

1 reference

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 April 2017

1 reference

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 April 2017

1 reference

High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications

21 April 2017

1 reference

Establishment of a chemical synthetic lethality screen in cultured human cells

21 April 2017

1 reference

Systematic functional analysis of the Caenorhabditis elegans genome using RNAi

21 April 2017

1 reference

Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library

21 April 2017

1 reference

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 April 2017

1 reference

A system for stable expression of short interfering RNAs in mammalian cells

21 April 2017

1 reference

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

21 April 2017

1 reference

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

21 April 2017

1 reference

Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis

21 April 2017

1 reference

Protein degradation and protection against misfolded or damaged proteins

21 April 2017

1 reference

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 April 2017

1 reference

Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes

21 April 2017

1 reference

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 April 2017

1 reference

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 April 2017

1 reference

Choosing anticancer drug targets in the postgenomic era.

21 April 2017

1 reference

Using cancer genetics to guide the selection of anticancer drug targets

31 March 2020

1 reference

Gleevec: prototype or outlier?

31 March 2020

1 reference

Principles for the buffering of genetic variation

31 March 2020

1 reference

Synthetic enhancement in gene interaction: a genetic tool come of age.

31 March 2020

1 reference

Mutation load, functional overlap, and synthetic lethality in the evolution and treatment of cancer

31 March 2020

1 reference

Emerging uses for genomic information in drug discovery

31 March 2020

1 reference

From large networks to small molecules

31 March 2020

1 reference

Synthetic dosage lethality

31 March 2020

1 reference

Isolation of ORC6, a component of the yeast origin recognition complex by a one-hybrid system

31 March 2020

1 reference

Integrating genetic approaches into the discovery of anticancer drugs

31 March 2020

1 reference

Role of the retinoblastoma protein in the pathogenesis of human cancer

31 March 2020

1 reference

E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis

31 March 2020

1 reference

Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.

31 March 2020

1 reference

Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells

31 March 2020

1 reference

Chemosensitivity linked to p73 function

31 March 2020

1 reference

Heat shock protein 90 as a molecular target for cancer therapeutics

31 March 2020

1 reference

Altered states: selectively drugging the Hsp90 cancer chaperone

31 March 2020

1 reference

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update

31 March 2020

1 reference

Proteasome inhibition as a novel therapeutic target in human cancer.

31 March 2020

1 reference

Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint

31 March 2020

1 reference

Differential regulation of E2F transactivation by cyclin/cdk2 complexes

31 March 2020

1 reference

Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation

31 March 2020

1 reference

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

31 March 2020

1 reference

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

31 March 2020

1 reference

Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo

31 March 2020

1 reference

Proliferation of cancer cells despite CDK2 inhibition.

31 March 2020

1 reference

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

31 March 2020

1 reference

Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells

31 March 2020

1 reference

The synthesis of protein(S) for chromosome condensation may be regulated by a post-transcriptional mechanism

31 March 2020

1 reference

ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

31 March 2020

1 reference

ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation

31 March 2020

1 reference

Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis

31 March 2020

1 reference

Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo

31 March 2020

1 reference

Consequences of nonadaptive alterations in cancer

31 March 2020

1 reference

Gene deletion: a new target for cancer chemotherapy

31 March 2020

1 reference

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

31 March 2020

1 reference

Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells.

31 March 2020

1 reference

Combining biological networks to predict genetic interactions

31 March 2020

1 reference

Use of isogenic human cancer cells for high-throughput screening and drug discovery

31 March 2020

1 reference

Genetic synthetic lethality screen at the single gene level in cultured human cells

31 March 2020

1 reference

F16, a mitochondriotoxic compound, triggers apoptosis or necrosis depending on the genetic background of the target carcinoma cell

31 March 2020

1 reference

A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth.

31 March 2020

1 reference

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway.

31 March 2020

1 reference

Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations.

31 March 2020

1 reference

Systematic discovery of multicomponent therapeutics

31 March 2020

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

Drug-like properties and the causes of poor solubility and poor permeability

31 March 2020

1 reference

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.

31 March 2020

1 reference

Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription

31 March 2020

1 reference

Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action

31 March 2020

1 reference

Genomic profiling of drug sensitivities via induced haploinsufficiency.

31 March 2020

1 reference

Drug target validation and identification of secondary drug target effects using DNA microarrays

31 March 2020

1 reference

lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48.

31 March 2020

1 reference

lin-35/Rb and ubc-18, an E2 ubiquitin-conjugating enzyme, function redundantly to control pharyngeal morphogenesis in C. elegans

31 March 2020

1 reference

fzr-1 and lin-35/Rb function redundantly to control cell proliferation in C. elegans as revealed by a nonbiased synthetic screen

31 March 2020

1 reference

Synthetic lethality of retinoblastoma mutant cells in the Drosophila eye by mutation of a novel peptidyl prolyl isomerase gene

31 March 2020

1 reference

Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition

31 March 2020

1 reference

RNAi and HTS: exploring cancer by systematic loss-of-function

31 March 2020

1 reference

Stable suppression of tumorigenicity by virus-mediated RNA interference

31 March 2020

1 reference

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

31 March 2020

1 reference

A resource for large-scale RNA-interference-based screens in mammals.

31 March 2020

1 reference

Enzymatic production of RNAi libraries from cDNAs.

31 March 2020

1 reference

Identification of Modulators of TRAIL-Induced Apoptosis via RNAi-Based Phenotypic Screening

31 March 2020

1 reference

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

31 March 2020

1 reference

Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens.

31 March 2020

1 reference

RNAi living-cell microarrays for loss-of-function screens in Drosophila melanogaster cells.

31 March 2020

1 reference

DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray

31 March 2020

1 reference

Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy

31 March 2020

1 reference

Characterization of synthetic DNA bar codes in Saccharomyces cerevisiae gene-deletion strains

31 March 2020

1 reference

Simultaneous identification of bacterial virulence genes by negative selection.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1691

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1510652

1052792626

0 references

1510652

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference